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The transmembrane adaptor PAG (Cbp) has been
proposed to mediate membrane recruitment of
Csk, a cytoplasmic protein tyrosine kinase playing
a critical inhibitory role during T cell activation, by in-
activating membrane-associated Src kinases. How-
ever, this model has not been validated by genetic
evidence. Here, we demonstrate that PAG-deficient
mice display enhanced T cell activation responses
in effector, but not in naive, T cells. PAG-deficient
mice also have augmented T cell-dependent autoim-
munity and greater resistance to T cell anergy. Inter-
estingly, in the absence of PAG, Csk becomes more
associated with alternative partners; i.e., phospha-
tase PTPN22 and Dok adaptors. Combining PAG
deficiency with PTPN22 or Dok adaptor deficiency
further enhances effector T cell responses. Unlike
PAG, Cbl ubiquitin ligases inhibit the activation of
naive, but not of effector, T cells. Thus, Csk-associ-
ating PAG is a critical component of the inhibitory
machinery controlling effector T cell activation in
cooperation with PTPN22 and Dok adaptors.
INTRODUCTION
T cell activation results from engagement of the T cell receptor
(TCR) by antigen peptides and major histocompatibility complex
(MHC) molecules displayed by antigen-presenting cells (APCs)
(Weiss and Littman, 1994). TCR signaling is instigated by protein
tyrosine phosphorylation, which is initiated by Src family en-
zymes, a group of intracellular protein tyrosine kinases (PTKs)
associated with the plasma membrane inner leaflet. The Src
kinases in T cells, Lck and Fyn, mediate this effect largely2776 Cell Reports 17, 2776–2788, December 6, 2016 ª 2016 The Au
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motifs (ITAMs) in TCR-associated CD3 and z chains. ITAM
tyrosine phosphorylation enables recruitment of another PTK,
ZAP-70, which phosphorylates other proteins, leading to effector
functions.
The enzymatic activity of Src kinases is regulated by tyrosine
phosphorylation (Veillette et al., 2002). Phosphorylation of a
tyrosine (Y) in the kinase domain (Y394 in Lck, Y417 in Fyn)
leads to activation. This is mediated by autophosphorylation
and reversed by protein tyrosine phosphatases (PTPs) such as
PTPN22 and SHP-1. Defects in these phosphatases, in partic-
ular PTPN22, are linked to autoimmune diseases in humans
(Rhee and Veillette, 2012; Stanford and Bottini, 2014). In
contrast, phosphorylation of a carboxyl-terminal tyrosine (Y505
in Lck, Y528 in Fyn) inactivates Src kinases. This is mediated
by another PTK, Csk, and is reversed by the transmembrane
PTP CD45. Although Src kinases are membrane-bound, Csk is
cytoplasmic. Thus, Csk needs to bind membrane-associated
molecules to be near Src kinases.
A strong candidate for recruiting Csk to the plasma mem-
brane is the transmembrane adaptor phosphoprotein associ-
ated with glycosphingolipid-enriched microdomains (PAG),
also known as Cbp (Brdicka et al., 2000; Hrdinka and Horejsi,
2014; Kawabuchi et al., 2000; Simeoni et al., 2008). Mem-
brane-bound PAG is also targeted to lipid rafts, where large
pools of Src kinases reside. PAG is prominently tyrosine-phos-
phorylated in unstimulated T cells (Brdicka et al., 2000; Davidson
et al., 2003). This phosphorylation enables binding to Csk by way
of tyrosine 314 (Y314) of PAG and the Src homology 2 (SH2)
domain of Csk. Upon TCR stimulation, PAG is dephosphorylated
and dissociates from Csk (Brdicka et al., 2000; Davidson et al.,
2003; Torgersen et al., 2001). This event is presumed to alleviate
the suppressive effect of Csk on Src kinases.
In support of the inhibitory role of Csk in TCR signaling, phar-
macological inhibition of Csk in mature T cells augmented T cell
activation (Manz et al., 2015). Conversely, Csk overexpression inthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
a T cell line suppressed T cell activation (Chow et al., 1993; Manz
et al., 2015). Furthermore, Csk-deficient (knockout [KO]) mice
exhibited severe T cell developmental abnormalities (Schmedt
et al., 1998; Tan et al., 2014). Although it had been presumed
that PAG mediates membrane recruitment of Csk in T cells,
two groups reported that PAG KO mice had no overt T cell
phenotype (Dobenecker et al., 2005; Xu et al., 2005). This obser-
vation raised the possibility that PAG is not responsible for mem-
brane recruitment of Csk or, alternatively, that other Csk-binding
molecules provide this function in the absence of PAG.
To resolve these matters, we further evaluated T cell functions
of PAG-deficient mice. As reported (Dobenecker et al., 2005;
Xu et al., 2005), PAG KO mice displayed no obvious alterations
in T cell development and had unaltered T cell activation re-
sponses when freshly isolated (naive) T cells were analyzed. In
contrast, these mice displayed increased activation responses
in vitro and in vivo when previously activated (effector) T cells
were assessed. In the absence of PAG, Csk became more
extensively associated with alternative Csk-interacting proteins
(namely, PTPN22 and Dok adaptors), which cooperated with
PAG to suppress activation of previously activated T cells.
Last, unlike mice lacking PAG, PTPN22, or Dok adaptors, mice
genetically deficient for Cbl ubiquitin ligases had augmented
activation responses in freshly isolated T cells, suggesting that
a distinct set of inhibitory effectors, including the Cbl proteins,
is controlling TCR signaling in naive T cells.
RESULTS
PAG-Deficient Mice Display Augmented Responses in
Previously Activated, but Not in Freshly Isolated, T Cells
To elucidate the role of PAG in T cells, the effect of PAG defi-
ciency was examined using a previously described PAG KO
mouse (Figure 1A; Lindquist et al., 2011; Yang and Seed,
2003). As reported, PAG KO mice had no alterations in the
numbers of various subsets of thymocytes compared with
wild-type mice (Table S1; Dobenecker et al., 2005; Xu et al.,
2005). They also had no significant change in the numbers of
all T cell subsets tested (Table S1). Levels of antibodies and
germinal center B cells were also not affected (Table S2). Similar
findings were made with young (1.5- to 3-month-old) and aged
(9- to 13-month-old) mice (Tables S1 and S2).
To study functional responses, we focused on CD4+ T cells.
Freshly isolated (ex vivo) PAG KO T cells stimulated with anti-
bodies against CD3 (anti-CD3) alone or anti-CD3 plus anti-
CD28 showed normal proliferation and cytokine production
comparedwith wild-type T cells (Figure S1A). In striking contrast,
previously activated PAG KO T cells (i.e., cells that have encoun-
tered a previous stimulation) demonstrated increased thymi-
dine incorporation as well as augmented secretion of interferon
(IFN) g, interleukin-2 (IL-2), and IL-4 in comparison with wild-
type T cells (Figure 1B). These effects were not seen with phorbol
myristate acetate (PMA) and ionomycin (P+I), which trigger acti-
vation by bypassing proximal TCR signaling (Figure 1B).
The superantigen staphylococcal enterotoxin B (SEB), in the
presence of APCs, triggers activation of Vb8.2+ CD4+ T cells.
Although freshly isolated PAG KO T cells did not have altered re-
sponses to SEB and APCs (Figure S1B), previously activatedPAG KO T cells showed significantly augmented proliferation
and IFN-g production compared with wild-type T cells (Fig-
ure 1C). No difference in the abundance of Vb8.2+ CD4+ T cells
existed between wild-type and PAG KO mice (Table S1).
Likewise, when PAG KO mice were bred with MHC class
II-restricted pigeon cytochrome c (PCC)-specific TCR transgenic
mice, freshly isolated PAG KO T cells did not show an altered
ability to respond to PCC peptide and APCs (Figure S1C). How-
ever, previously activated PAG KO T cells displayed increased
IFN-g secretion and, to a lesser extent, thymidine incorporation
in comparison with wild-type T cells (Figure 1D; Figure S1D).
The effect of PAGdeficiencywas also ascertained in an ex vivo
antigen re-stimulation assay. Mice were immunized in the foot
pad with ovalbumin (OVA) in the presence of adjuvant. After
9 days, CD4+ T cells from draining lymph nodes were re-stimu-
lated in vitro with OVA and APCs. T cells from PAG KOmice dis-
played markedly increased OVA-induced proliferation and IFN-g
production (Figure 1E; Figure S1E).
To confirm that the increased responses of PAG KO T cells
were due to PAG deficiency, PAG expression was reconstituted
using retrovirus-mediated gene transfer of either wild-type PAG
or a PAGmutant unable to bind Csk (PAG tyrosine 314 to phenyl-
alanine 314 [Y314F]). The levels of expression of the two proteins
were similar (Figure 1F). Wild-type PAG, but not PAG Y314F,
corrected the enhanced SEB-induced proliferation and IFN-g
production of PAG KO T cells (Figure 1G; Figure S1F).
Hence, loss of PAG in CD4+ T cells augmented antigen recep-
tor-mediated responses in previously activated, but not in freshly
isolated, T cells. This effect was corrected by wild-type PAG but
not by a PAG mutant unable to bind Csk.
Increased TCR Signaling in Previously Activated
PAG-Deficient T Cells
The effect of PAG deficiency on TCR signaling was assessed.
Freshly isolated PAG KO T cells showed no alteration of
TCR-triggered protein tyrosine phosphorylation compared with
wild-type T cells (Figure 2A). This was observed whether cells
were triggered with anti-CD3 or anti-TCR (data not shown).
There was also no change in the activation of Erk, Akt, and cal-
cium fluxes (Figures S2A and S2B). In contrast, previously acti-
vated PAG KO T cells demonstrated prominently enhanced
TCR-induced protein tyrosine phosphorylation compared with
wild-type T cells (Figure 2A). This effect involved all TCR-regu-
lated substrates, including ITAMs and ZAP-70, as well as
Lck and Fyn, which showed augmented phosphorylation at
their activating tyrosine (Y394 for Lck and Y417 for Fyn) (Fig-
ures 2A and 2B; Figure S2C). The identity of Lck and Fyn in
the phospho-Src kinase immunoblots was confirmed by immu-
nodepletion (Figure S2D). Surprisingly, little or no appreciable
effect was seen on phosphorylation of the inhibitory tyrosine
of Lck, Y505 (Figure 2B). Previously activated PAG KO T cells
also showed increased TCR-triggered calcium fluxes (Fig-
ure 2C). Nevertheless, they exhibited minimal or no increase
in activation of Erk, Akt, c-Jun N-terminal kinase (JNK), PKC-q,
p38 kinase, and inhibitor of kBa (IkBa) (Figure 2D; Figure S2E).
A quantitation of these findings is shown in Figure S2F.
To ensure that the increased TCR-evoked signals in PAG
KO mice were due to PAG deficiency, wild-type PAG wasCell Reports 17, 2776–2788, December 6, 2016 2777
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Figure 1. Enhanced Responses of Previously Activated T Cells in PAG-Deficient Mice
(A) Purified CD4+ T cells from wild-type (WT) or PAG KOmice were activated in vitro with anti-CD3 plus anti-CD28 and expanded in IL-2. Expression of PAG was
verified by immunoblotting of total cell lysates.
(B) As in (A), except that cells were re-stimulated with anti-CD3 (0.05 mg/mL), anti-TCR (0.05 mg/mL) plus anti-CD28 (1 mg/mL), or P+I. Thymidine incorporation
(expressed hereafter as counts per minute [CPM]) and production of IFN-g, IL-2, or IL-4 were monitored. Means with SD of triplicate values are shown.
(C) Same as in (B), except that cells were re-stimulated with the indicated concentrations of SEB and APCs.
(D) Purified CD4+ T cells from TCR AND transgenic mice were first activated in vitro with anti-CD3 plus anti-CD28 and then re-stimulated with the indicated
concentrations of PCC peptide and APCs or with P+I.
(E) Mice (two mice in each group) were immunized with OVA and adjuvant. After 9 days, CD4+ T cells were isolated and re-stimulated with the indicated
concentrations of OVA andWT splenocytes or P+I. After 4–5 days (for OVA re-stimulation) or 2 days (for P+I), production of IFN-gwasmonitored as detailed in (B).
(F and G) CD4+ T cells activated in vitro with anti-CD3 plus anti-CD28 were infected with retroviruses encoding GFP alone or in combination with WT PAG or
PAG Y314F. After sorting of GFP-positive cells, expression of PAG was verified by immunoblotting of total cell lysates (F). Responsiveness to SEB was also
examined, as detailed in (C) (G).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n > 25 (A), n = 4 (B), n = 6 (C), n = 4 (D), n = 3 (E), and n = 2 (F and G). See also Figure S1.re-introduced using retroviral infection (Figure 2E). Re-expres-
sion of PAG, but not of an empty vector, corrected the
augmented TCR-triggered protein tyrosine phosphorylation of
PAG KO cells (Figure 2F).
Combined, these findings showed that PAG deficiency glob-
ally enhanced TCR signaling, including activation of Src kinases.
As was the case for functional responses, these effects were
observed in previously activated, but not in freshly isolated,
T cells.2778 Cell Reports 17, 2776–2788, December 6, 2016PAG-Deficient Mice Have Enhanced Susceptibility to
Experimental Autoimmune Encephalomyelitis
To validate in vivo the notion that PAG controls the activation of
previously activated cells, susceptibility to experimental auto-
immune encephalomyelitis (EAE), a model of T cell-dependent
autoimmunity, was examined. In this model, mice are immu-
nizedwith amyelin oligodendrocyte glycoprotein (MOG)-derived
peptide. MOG-specific effector CD4+ T cells subsequently
migrate to the nervous system, where they are re-activated by
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Figure 2. Increased TCR Signaling in Previously Activated PAG-Deficient T Cells
(A) Ex vivo or previously activated CD4+ T cells fromWT or PAG KOmice were stimulated for the indicated times with anti-CD3. Protein tyrosine phosphorylation
was then detected by immunoblotting of total cell lysates with anti (a)-phosphotyrosine (P.tyr). An 8% gel was used to detect overall protein tyrosine phos-
phorylation (first panel). A 15%gel was used to detect phosphorylated ITAM-containing z chains (p23, p21, and p16) (second panel). Phosphorylated ZAP-70 and
total ZAP-70 were also detected (third and fourth panels) by immunoblotting with phospho-specific anti-ZAP-70 and anti-ZAP-70, respectively. The positions of
prestained molecular mass markers are shown on the right.
(B) Phosphorylation of protein tyrosine kinases in previously activated CD4+ T cells was assessed as detailed for (A) using phospho-specific antibodies.
(C) After loading with Indo-1, previously activated T cells were stimulated with anti-TCR (left) or ionomycin (iono, right). Changes in intracellular calcium were
assessed by measuring the ratio between calcium-bound Indo-1 and calcium-free Indo-1 using flow cytometry. The arrow indicates when the stimulus was
added.
(D) Same as (B), except that cell lysates were probed by immunoblotting with the indicated antibodies.
(E and F) Previously activated CD4+ T cells were infected with retroviruses encoding GFP alone or in combination with WT PAG. After sorting GFP-positive cells,
expression of PAG was verified by immunoblotting of total cell lysates (E). Anti-CD3-induced protein tyrosine phosphorylation was also examined (F).
Representative of n = 3 (A), n = 4 (B), n = 2 (C), n = 3 (D), and n = 2 (E and F). See also Figure S2.endogenous MOG. PAG KO mice were much more susceptible
to EAE thanwild-typemice (Figure 3A). Moreover, after a booster
immunization, given at a time when clinical signs of EAE had
resolved, PAG KO mice developed the disease again, whereas
wild-type mice were tolerant (Figure 3A).
To confirm that the increased susceptibility to EAE was due to
functional differences in CD4+ T cells, an ex vivo antigen re-stim-
ulation assay was performed. Re-stimulation of PAG KO CD4+
T cells with MOG peptide in the presence of APCs resulted in
greater thymidine incorporation as well as augmented secre-
tion of IFN-g and IL-17, two cytokines that have a key pathogenic
role in EAE (Figure 3B; Figure S3A). Adoptive transfer experi-
ments were also performed. CD4+ T cells were purified from
MOG-immunized mice and transferred into RAG-1 KO mice,and their ability to induce EAE was monitored. Mice injected
with PAG KO T cells displayed a greater severity of EAE than
mice injected with wild-type T cells (Figure 3C). The poor induc-
tion of EAE by wild-type T cells was not due to lack of function-
ality because EAE was induced when three timesmore wild-type
T cells were transferred (Figure 3D).
Therefore, loss of PAG increased the sensitivity of mice to
EAE. Moreover, it decreased tolerance of EAE. These effects
were T cell-intrinsic.
Increased Resistance to T Cell Anergy in PAG-Deficient
Mice
Our previous studies showed that T cells from transgenic
mice overexpressing PAG had decreased resistance to anergyCell Reports 17, 2776–2788, December 6, 2016 2779
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Figure 3. Increased Susceptibility to EAE and Resistance to Anergy in Mice Lacking PAG
(A) WT or PAG KO mice (5–8/group) were immunized with MOG peptide in the presence of adjuvant followed by pertussis toxin. Then they were followed for
neurological deficits. A booster immunization was also given on day 35 (arrow). Means of clinical scores with one-sided SEM are depicted. p = 0.002.
(B) CD4+ T cells were purified from spleens of MOG-immunizedmice. They were then re-stimulated in vitro with the indicated concentrations of MOGpeptide and
WT splenocytes. Proliferation and cytokine production were analyzed. Means with SD are shown.
(C) As in (B), except that T cells were transferred into RAG-1 KO mice (5–6/group), and induction of EAE was monitored as detailed in Experimental Procedures.
Means of clinical scores with one-sided SEM are depicted.
(D) Same as (C), except that three times greater numbers of T cells from WT mice were transferred.
(E and F) OVA-specific OT-II TCR transgenic mice were injected intravenously (i.v.) twice with soluble OVA peptide or PBS alone. After 10 days, splenic
CD4+ CD44hi Va2+ T cells were isolated by cell sorting and re-stimulated with the indicated concentrations of OVA peptide and APCs. Proliferation and IL-2
secretion were monitored. The anergy index is the ratio of thymidine incorporation or IL-2 secretion between cells from PBS-injected and OVA peptide-injected
mice. Means with SD of triplicate values are depicted (E). Anergy indices are represented graphically (F).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n = 2 (A), n = 2 (B), n = 2 (C), n = 2 (D), and n = 2 (E and F). See also Figure S3.compared towild-type T cells (Davidson et al., 2007). However, a
role of PAG in anergy had not been supported by earlier studies
of PAG KO mice (Dobenecker et al., 2005; Xu et al., 2005). To
clarify the role of PAG in anergy, PAG KO mice were tested in
two models of T cell anergy. First, effector CD4+ T cells, gener-
ated by stimulation with anti-CD3 plus anti-CD28, were aner-
gized in vitro by treatment with anti-CD3 alone. Anergy induction
was assessed bymonitoring proliferation and IL-2 secretion after
re-stimulation with anti-TCR plus anti-CD28. In wild-type T cells,2780 Cell Reports 17, 2776–2788, December 6, 2016anti-CD3 treatment suppressed subsequent T cell responses, as
reflected by an ‘‘anergy index’’ above 1.0. However, the opposite
occurred in PAG KO T cells; anti-CD3 enhanced subsequent
T cell responses, resulting in an anergy index below 1.0 (Figures
S3B and S3C).
Second, anergy was induced in vivo by injecting soluble OVA
peptide into OVA-specific OT-II TCR transgenic mice. CD4+
T cells were subsequently isolated and tested by re-stimulation
with OVA peptide and APCs. Injection of soluble OVA peptide
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Figure 4. Increased Association of Csk with PTPN22 in PAG-Deficient T Cells
(A and B) The expression levels of various regulators of TCR signaling in ex vivo or previously activated CD4+ T cells fromWT or PAG KO mice were analyzed by
immunoblotting of total cell lysates with the indicated antibodies. Relative levels of expression are shown below each panel (A). Expression of CD45 was also
assessed by flow cytometry using antibodies recognizing all CD45 isoforms, CD45RA, or CD45RO. iso., isotype control (B).
(C and D) The association of Csk with PTPN22 or PAG was assessed in previously activated CD4+ T cells in the absence or presence of stimulation by anti-TCR
using immunoprecipitation (C). A quantitation of the extent of Csk-PTPN22 and Csk-PAG association is shown (D). T cells from PTPN22 KO mice were analyzed
as a control.
Representative of n = 2–6, depending on protein (A), n = 2 (B), and n = 2 (C).suppressed subsequent T cell responses in wild-type mice. This
effect was much weaker in PAG KO mice, as reflected by the
lower anergy indices (Figures 3E and 3F).
Thus, PAG KO mice displayed increased resistance to anergy
in the two experimental models tested.
Increased Association of Csk with PTPN22 in
PAG-Deficient T Cells
The finding that the alterations of T cell functions in PAGKOmice
weremilder than those inmice lacking Csk (Schmedt et al., 1998)
suggested that compensatory mechanisms might be limiting
TCR signaling in PAG KO mice. To address this idea, we tested
the effect of PAG deficiency on the expression of various TCR
signaling molecules. PAG KO T cells displayed no change in
expression of Lck, Fyn, Csk, CD45, PTPN22, SHP-1, or the ubiq-
uitin ligases c-Cbl and Cbl-b compared with wild-type T cells
both in freshly isolated and in previously activated T cells (Figures
4A and 4B). Of note, however, previously activated T cells dis-
played 4- to 5-fold higher levels of PTPN22 and 2.0- to 2.5-fold
higher levels of Cbl-b than freshly isolated T cells (Figure 4A).
Moreover, in protein gels, CD45 migrated as a doublet in freshly
isolated T cells but as a single species in previously activatedT cells, likely reflecting variations in CD45 isoforms (Figures 4A
and 4B; Rhee and Veillette, 2012; Zikherman and Weiss, 2008).
Weexamined theassociationofCskwithPTPN22,whichcoop-
erates with Csk in inhibition of TCR signaling (Rhee and Veillette,
2012). In wild-type T cells, Csk was minimally associated with
PTPN22 prior to TCR triggering (Figures 4C and 4D). This interac-
tionwasmarkedly increasedbyTCRstimulation.Conversely,Csk
was strongly associated with PAG prior to TCR stimulation, and
this association was decreased by TCR stimulation (Figures 4C
and 4D), as reported previously (Brdicka et al., 2000; Davidson
et al., 2003). In PAG KO T cells, however, the association of Csk
with PTPN22 was markedly enhanced (more than 10-fold) in un-
stimulated cells compared with wild-type T cells (Figures 4C
and 4D). This association was not affected by TCR stimulation.
Thus, in PAG-deficient T cells, expression of various compo-
nents of the TCR signaling machinery was not altered. Nonethe-
less, the Csk-PTPN22 interaction was constitutively augmented.
PTPN22 Cooperates with PAG to Suppress Effector
T Cell Responses
To assess whether PTPN22 might attenuate the effect of
PAG deficiency in T cells, mice lacking both PAG and PTPN22Cell Reports 17, 2776–2788, December 6, 2016 2781
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Figure 5. PTPN22 Cooperates with PAG to Suppress the Responses of Previously Activated T Cells
(A) Previously activated CD4+ T cells from WT, PAG KO, PTPN22 KO, or PAG PTPN22 DKO mice were stimulated with the indicated antibodies or P+I, as in
Figure 1B. Proliferation and IFN-g production were monitored. Means with SD of triplicates are shown.
(B) Same as in (A), except that cells were re-stimulated with the indicated concentrations of SEB and APCs.
(C) Previously activated CD4+ T cells from the indicated mice were stimulated for the indicated times with anti-TCR plus anti-CD28. Phosphorylation was then
detected by immunoblotting of total cell lysates with antibodies against P.tyr (first panel), activated Src kinases (second panel), activated ZAP-70 (fifth panel), or
tyrosine phosphorylated phospholipase C (PLC) g1 (seventh panel). The positions of molecular mass markers are shown on the right.
(D) Calcium fluxes in previously activated T cells were analyzed as detailed for Figure 2C.
(E) Same as in (C), except that total cell lysates were probed by immunoblotting with the indicated antibodies.
**p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n = 2 (A), n = 2 (B), n = 3 (C), n = 2 (D), and n = 3 (E). See also Figure S4.(PAG PTPN22 double knockout [DKO]) were generated and
analyzed in parallel with mice lacking PAG or PTPN22 alone (Fig-
ure S4A). Contrary to PAG KO or PTPN22 KO T cells, freshly iso-
lated PAGPTPN22DKOT cells displayed a small increase in pro-
liferation and IFN-gproduction in response to anti-CD3, anti-TCR
plus anti-CD28, or SEB compared with wild-type T cells (Figures
S4B and S4C). A small increase in TCR-triggered protein tyrosine
phosphorylation was also observed (Figure S4D).
More strikingly, however, when previously activated T cells
were studied, PAG PTPN22 DKO cells exhibited markedly2782 Cell Reports 17, 2776–2788, December 6, 2016enhanced proliferation and IFN-g secretion in response to these
stimuli compared with PAG KO or PTPN22 KO cells (Figures 5A
and 5B). They also exhibited greater TCR-triggered protein
tyrosine phosphorylation and calcium fluxes (Figures 5C and
5D; Figure S4E). There was little or no effect on Erk, p38, and
Akt (Figure 5E; Figure S4E). In keeping with an earlier report
(Hasegawa et al., 2004), previously activated PTPN22 KO
Tcells, but not freshly isolatedPTPN22KOTcells, also displayed
enhanced TCR-triggered protein tyrosine phosphorylation, cal-
cium fluxes, and effector responses compared with wild-type
A B
C
D E F
Figure 6. Dok Family Adaptors Cooperate with PAG to Suppress Responses of Previously Activated T Cells
(A) Previously activated CD4+ T cells from WT or PAG KO mice were stimulated with anti-CD3. Overall protein tyrosine phosphorylation, including tyrosine
phosphorylation of two proteins of 62 (p62) and 56 (p56) kDa (shown by arrows), is depicted in the first panel (left). Tyrosine phosphorylation of Dok-1 and Dok-2
was examined by immunoblotting of total cell lysates with a phospho-specific antibody recognizing Dok-1 and Dok-2 (second panel). The positions of molecular
mass markers are shown on the right. A quantitation of relative tyrosine phosphorylation of Dok-1 and Dok-2 is depicted on the right.
(B) Lysates of unstimulated, previously activated CD4+ T cells fromWT or PAG KOmice were immunoprecipitated with anti-Dok-1 or anti-Dok-2, and probed by
immunoblotting with anti-SHIP-1 or anti-Ras-GAP antibodies (left). Alternatively, lysates were immunoprecipitated with antibodies against Csk or normal rabbit
serum (NRS), and probed by immunoblotting with anti-Dok-1 (right). Quantitation of the extent of association is shown below each panel.
(C) Same as (B), except that cells were stimulated or not with anti-CD3, and only Dok-2 was immunoprecipitated.
(D) Previously activated CD4+ T cells from WT, PAG KO, Dok-1 KO, or PAG Dok-1 DKO mice were stimulated with SEB and APCs. Proliferation and IFN-g
production were monitored. Means of triplicates with SD are shown.
(E) Same as (D), except that PAG Dok-1 DKO cells were transduced with scrambled or Dok-2-specific shRNAs.
(F) Same as (D), except that previously activated T cells from WT, PAG KO, SHIP-1 KO, or PAG SHIP-1 DKO mice were studied.
**p < 0.01, ***p < 0.001, ****p < 0.0001. Representative of n = 3 (A), n = 4 (B), n = 4 (C), n = 3 (D), n = 3 (E), and n = 2 (F). See also Figures S5 and S6.T cells (Figures 5A–5D). These changes were analogous to those
seen in PAG KO T cells.
Therefore, loss of PTPN22 accentuated the effect of PAG defi-
ciency in previously activated CD4+ T cells, seemingly by further
enhancingoverall TCR-triggeredprotein tyrosinephosphorylation.
Augmented Tyrosine Phosphorylation of Dok Adaptors
in PAG-Deficient T Cells
We noted that previously activated PAG KO T cells exhibited
augmented tyrosine phosphorylation of two proteins, p62 and
p56, compared with wild-type T cells (Figure 6A). These proteins
might represent Dok-1 and Dok-2, two inhibitory adaptor mole-
cules associating with Csk and with other inhibitory effectors,such as the lipid phosphatase SHIP-1 and Ras-GTPase acti-
vating protein (Ras-GAP) (Veillette et al., 2002). Immunoblotting
with phospho-specific antibodies jointly recognizing Dok-1 and
Dok-2 showed that Dok-1 and Dok-2 were indeed hyperphos-
phorylated in PAGKO T cells (Figure 6A). For Dok-1, the increase
was prominent in unstimulated T cells and attenuated by
TCR stimulation. For Dok-2, the enhancement was minimal in
unstimulated T cells and accentuated by TCR stimulation (Fig-
ure 6A). These findings were confirmed by immunoprecipitation
(Figure S5A).
Immunoblotting of Dok-1 or Dok-2 immunoprecipitates with
anti-SHIP-1 or anti-Ras-GAP antibodies revealed that Dok-1
and Dok-2 were more extensively associated with SHIP-1 andCell Reports 17, 2776–2788, December 6, 2016 2783
Ras-GAP in PAGKOT cells compared with wild-type T cells (Fig-
ure 6B). For Dok-2, this effect was enhanced by TCR stimulation
(Figure 6C). In addition, Dok-1 was more associated with Csk in
PAG KO T cells (Figure 6B).
Therefore, loss of PAG resulted in enhanced tyrosine phos-
phorylation of Dok-1 and Dok-2 as well as augmented associa-
tion of these adaptors with Csk, SHIP-1, and Ras-GAP, three
known inhibitory molecules.
Dok Adaptors and SHIP-1 Cooperate with PAG to Inhibit
Effector T Cell Responses
To test whether the Dok adaptors might restrict the in-
fluence of PAG deficiency, mice lacking both PAG and Dok-1
(PAG Dok-1 DKO) were generated and analyzed together with
mice lacking PAG or Dok-1 alone (Figure S5B). Like PAG KO
T cells, Dok-1 KO T cells displayed enhanced T cell responses
in previously activated T cells but not in freshly isolated T cells
(Figure 6D; Figures S5C and S5D). However, PAG Dok-1 DKO
T cells did not show greater increases in T cell responses than
PAG KO or Dok-1 KO T cells (Figure 6D; Figures S5C and
S5D). To probe the involvement of Dok-2, PAG KO T cells or
PAGDok-1 DKOT cells were infected with retroviruses encoding
small hairpin RNAs (shRNA) against Dok-2. This resulted in an
80% reduction of Dok-2 expression (Figure S6A). Compared
with previously activated PAG Dok-1 DKO T cells transduced
with scrambled shRNAs, those transduced with Dok-2 shRNAs
demonstrated significantly augmented SEB-induced prolifera-
tion and IFN-g production (Figure 6E). A small increase in
TCR-triggered protein tyrosine phosphorylation was also seen
(Figure S6B). These effects were not seen in Dok-2 shRNA-trans-
duced PAG KO T cells (Figures S6C and S6D). These observa-
tions implied that loss of both Dok-1 and Dok-2, but not of either
adaptor alone, increased the effect of PAG deficiency in previ-
ously activated T cells.
Given that SHIP-1 is a prime binding partner of members of the
Dok family (Veillette et al., 2002), we tested the possibility that
SHIP-1 was involved in the compensation effected by the Dok
adaptors in PAG KO T cells by analyzing PAG SHIP-1 DKO
T cells (Figure S6E). Previously activated PAG SHIP-1 DKO
T cells showed greater SEB-triggered proliferation and cytokine
production than PAG KO or SHIP-1 KO T cells (Figure 6F).
TCR-triggered calcium fluxes, a known target of SHIP-1-medi-
ated inhibition, were also enhanced (Figure S6F).
Hence, combined loss of Dok-1 and Dok-2 further enhanced
the responses of previously activated PAG KO T cells. A similar
effect was seen with loss of SHIP-1, a known effector of
Dok-mediated inhibition.
Loss of Cbl Ubiquitin Ligases Enhances Responses in
Freshly Isolated T Cells
The finding that PAG deficiency had no appreciable effect on
responses in freshly isolated T cells (Dobenecker et al., 2005;
Xu et al., 2005; this report) implied that alternative mechanisms
were responsible for inhibiting TCR signaling in these cells.
Although many candidates, such as other PTPs and various
ubiquitin ligases, may be involved, we focused on the Cbl
ubiquitin ligases, which cause degradation of tyrosine-phos-
phorylated substrates, in particular ZAP-70 (Huang and Gu,2784 Cell Reports 17, 2776–2788, December 6, 20162008; Thien and Langdon, 1998; Veillette et al., 2002; Zhang
et al., 2014). To test this idea, T cell responses were exam-
ined in mice lacking c-Cbl and Cbl-b, the two major Cbl pro-
teins expressed in T cells (Figure S7A). Unlike PAG KO mice,
c-Cbl Cbl-b DKO mice showed a marked enhancement of
TCR-evoked proliferation and IFN-g secretion in freshly isolated
T cells compared with wild-type mice (Figure 7A). Similar results
were obtained with naive CD4+ T cells purified by cell sorting
(Figure S7B). This was important because c-Cbl Cbl-b DKO
mice had amarked increase in the proportion of effector memory
T cells at steady state (Figure S7C). Significantly, and in contrast,
little or no difference in TCR-evoked proliferation and IFN-g
secretion was seen in previously activated c-Cbl Cbl-b DKO
T cells compared with wild-type T cells (Figure 7B).
Freshly isolated, but not previously activated, c-Cbl Cbl-b
DKO T cells also displayed a pronounced increase in TCR-trig-
gered protein tyrosine phosphorylation (Figure 7C; Figure S7D).
Unlike PAG KO T cells, this effect was restricted to a subset
of TCR-regulated substrates, especially p70 and p76. These
substrates likely represented ZAP-70 and SLP-76, a known
ZAP-70 substrate, as revealed by immunoblotting with phos-
pho-specific antibodies (Figure 7D; Figure S7D).
Interestingly, freshly isolated c-Cbl Cbl-b DKO T cells also dis-
played increased phosphorylation of Fyn and, to a lesser extent,
Lck at their activating tyrosine (Figure 7D; Figure S7D), raising
the possibility that the Cbl proteins were also inhibiting, directly
or indirectly, the function of Src kinases. Indeed, a previous
study has shown that c-Cbl induced degradation of activated
Fyn in T cells (Andoniou et al., 2000). However, because Cbl pro-
teins can behave not only as ubiquitin ligases but also as adap-
tors (Huang and Gu, 2008; Thien and Langdon, 1998; Veillette
et al., 2002; Zhang et al., 2014), it was possible that the Cbl pro-
teins were also inhibiting Fyn by recruiting Csk. In keeping with
this possibility, Csk co-immunoprecipitated with both c-Cbl
and Cbl-b (Figure 7E). The extent of this association was much
greater in TCR-stimulated T cells than in unstimulated T cells.
Therefore, unlike PAG deficiency, loss of Cbl proteins caused
increased T cell activation responses in freshly isolated or naive,
but not in previously activated, T cells. This effect correlated with
augmented tyrosine phosphorylation of selected TCR-regulated
substrates, in particular ZAP-70, SLP-76, and Fyn.
DISCUSSION
In this report, we found that PAG has a prominent effect on
secondary T cell responses. Previously activated, but not freshly
isolated, CD4+ T cells from PAG-deficient mice had increased
proliferation and cytokine production in response to anti-TCR
complex antibodies, superantigen, or antigen compared with
cells from wild-type mice. These alterations were corrected by
re-expression of wild-type PAG, but not of a PAG mutant unable
to interact with Csk (PAG Y314F), implying that they were likely
due to compromised Csk recruitment. PAG KO mice also dis-
played augmented susceptibility to EAE. Thus, PAG is a critical
negative regulator of T cell activation in vitro and in vivo. This
role had not been appreciated in earlier studies of PAG KO
mice, given that only freshly isolated T cells had been analyzed
(Dobenecker et al., 2005; Xu et al., 2005).
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Figure 7. Cbl Ubiquitin Ligases Inhibit Responses of Freshly Isolated T Cells
(A) Freshly isolated CD4+ T cells fromWT or c-Cbl Cbl-b DKO mice were activated in vitro with anti-CD3 (3 mg/mL), anti-TCR (3 mg/mL) plus anti-CD28 (1mg/mL),
or P+I. Proliferation and IFN-g production weremonitored. Means with SD of triplicates are shown. Ratio of values observed in c-Cbl Cbl-b DKO (Cbl DKO) T cells
compared with WT T cells, are shown at the bottom.
(B) Same as in (A), except that previously activated T cells were analyzed with anti-CD3 (0.1 mg/mL), or anti-TCR (0.1 mg/mL) plus anti-CD28 (1 mg/mL). Two mice
of each genotype were studied.
(C) Freshly isolated or previously activated CD4+ T cells fromWT or c-Cbl Cbl-b DKOmice were stimulated with anti-TCR plus anti-CD28. Overall protein tyrosine
phosphorylation was analyzed by anti-P.tyr immunoblotting. The positions of the substrates showing marked changes in tyrosine phosphorylation between
WT and c-Cbl Cbl-b DKO are indicated on the left and that of molecular mass markers on the right.
(D) Same as in (C), except that phosphorylation of specific substrates was analyzed using phospho-specific antibodies.
(E) WT T cells were stimulated or not with anti-CD3. After lysis, Csk was immunoprecipitated and probed by immunoblotting with antibodies against c-Cbl or
Cbl-b.
****p < 0.0001; ns, not significant. Representative of n = 2 (A), n = 2 (B), n = 2 (C), n = 2 (D), and n = 2 (E). See also Figure S7.Although a role for PAG in anergy was not recognized in earlier
studies of PAG KO mice (Dobenecker et al., 2005; Xu et al.,
2005), our previous studies of transgenic mice overexpressing
PAG suggested that PAG promotes T cell anergy (Davidson
et al., 2007), possibly reflecting its ability to inhibit signaling
by co-stimulatory receptors, which prevent anergy. Here we
observed that loss of PAG markedly reduced anergy induced
in vitro by anti-CD3 and in vivo by soluble OVA peptides. The
reason why PAG KO mice showed no defect in the anergy
models evaluated by the other groups remains to be elucidated.Previously activated, but not freshly isolated, PAG KO T cells
also displayed globally enhanced TCR-triggered protein tyro-
sine phosphorylation and calcium fluxes compared with wild-
type T cells. These effects were accompanied by augmented
phosphorylation of the activating tyrosine of the Src kinases
Lck and Fyn and were corrected by re-expression of wild-
type PAG. Therefore, the increased functional responses of
PAG KO T cells were likely due to hyperactive Src kinases, the
targets of Csk. However, PAG KO T cells showed little or
no appreciable decrease in phosphorylation of the inhibitoryCell Reports 17, 2776–2788, December 6, 2016 2785
tyrosine of Lck (Y505), the immediate target of Csk. Possibly, the
pool of TCR-activated Lck, which is regulated by PAG and Csk,
is too small to be discriminated from the total pool of Lck. Alter-
natively, when activated by loss of Y505 phosphorylation in the
absence of PAG or Csk, Lck molecules may rapidly re-phos-
phorylate at Y505.
Unlike protein tyrosine phosphorylation and calcium fluxes,
PAG KO T cells had little or no enhancement of TCR-mediated
activation of downstream effectors such as Erk, Akt, JNK,
PKC-q, p38, and IkBa. A similar observation was made with
PTPN22 KO T cells (Hasegawa et al., 2004; this report). In the
absence of PAGor PTPN22, a rate-limiting step or negative feed-
back mechanism may be restricting coupling to these down-
stream effectors. Interestingly, uncoupling to the Erk pathway
was also observed in T cells in which Csk was inactivated phar-
macologically (Tan et al., 2014). It was proposed that the actin
cytoskeleton physically restricted coupling of protein tyrosine
phosphorylation to the Erk pathway. A related mechanism may
be operational in PAG KO or PTPN22 KO T cells.
Compared with wild-type T cells, PAG KO T cells displayed
increased association of Csk with its partner PTPN22. This in-
crease might occur because loss of PAG releases a pool of
Csk that becomes available to bind PTPN22. Although PAG
and PTPN22 interact with distinct domains of Csk (Veillette
et al., 2002), PAG may restrict the accessibility of Csk through
steric hindrance, physical competition, conformational modifi-
cation, or spatial sequestration. There may also be a hierarchy
in binding of Csk to its partners, based on their abundance,
phosphorylation state, or affinity. Indeed, PAG KO T cells ex-
hibited enhanced tyrosine phosphorylation of Dok-1 and Dok-
2 and increased association of these adaptors with Csk and
also with SHIP-1 and Ras-GAP. Our observations suggested
that PTPN22 and Dok adaptors cooperate with PAG to restrict
responses of previously activated T cells. This notion was firmly
established by analyses of mice lacking PAG in combination
with PTPN22 or Dok adaptors. What is the purpose of having
multiple Csk partners to control activation of previously acti-
vated T cells? We postulate that this network enables recruit-
ment of Csk to multiple cellular locales, where Src kinases
are positioned, and may be needed for efficient control of
T cell activation. PAG may recruit Csk to lipid rafts, whereas
PTPN22 may bring it to tyrosine-phosphorylated ITAMs and
ZAP-70, which are targets of PTPN22 (Cloutier and Veillette,
1996). Likewise, Dok adaptors may recruit Csk to areas of acti-
vation of phosphatidylinositol 30 kinase, which triggers recruit-
ment of Dok adaptors by way of their pleckstrin homology
domain (Veillette et al., 2002).
Unlike previously activated PAG KO T cells, there was no
increase in T cell responses in freshly isolated PAG KO T cells.
A similar phenomenon was observed in PTPN22 KO and
Dok-1 KO T cells (Hasegawa et al., 2004; this report). In the
case of PTPN22, only stimulation by weak agonists revealed
an effect of PTPN22 deficiency in freshly isolated T cells
(Salmond et al., 2014). Hence, we presume that inhibitors other
than PAG, PTPN22, and Dok adaptors are suppressing activa-
tion of naive T cells. These inhibitors could provide alternative
mechanisms to recruit Csk to the membrane or could even sup-
press T cell activation independently of Csk.2786 Cell Reports 17, 2776–2788, December 6, 2016One candidate for controlling TCR-mediated responses in
freshly isolated T cells is the Cbl proteins. Indeed, we observed
that c-Cbl Cbl-b DKO mice displayed enhanced activation re-
sponses in freshly isolated, but not in previously activated,
T cells. This function may relate to the ability of Cbl proteins to
cause degradation of key effectors of TCR signaling, such as
ZAP-70 and Fyn, or to act as adaptors recruiting other inhibitory
molecules, including Csk (Huang and Gu, 2008; Thien and Lang-
don, 1998; Veillette et al., 2002; Zhang et al., 2014). In support of
the latter idea, we found that Csk co-immunoprecipitated with
the Cbl proteins, in particular in TCR-stimulated T cells. In addi-
tion to Cbl proteins, it is likely that other Csk-interacting proteins
also contribute to inhibition of naive T cells. These notions are
compatible with previous studies in which Csk was acutely
inhibited in freshly isolated T cells (Tan et al., 2014). Unlike Cbl
deficiency, inactivation of Csk resulted in a more global
enhancement of protein tyrosine phosphorylation. Furthermore,
it is possible that the network of Csk binding partners might differ
between freshly isolated and previously activated T cells.
In summary, our data provide evidence that PAG is a critical
negative regulator of TCR signaling and T cell activation in
effector T cells. This function seemingly relates to the ability of
PAG to recruit Csk to the plasma membrane, where Src kinases
are located. In this function, PAG cooperates with other
Csk-interacting proteins; namely, PTPN22 and Dok adaptors.
In contrast, PAG has no appreciable role in naive T cells, likely
because of the ability of other negative regulators, including
the Cbl proteins, to control TCR signaling in these cells. The
involvement of PAG in the control of effector T cell activation
may be crucial to enable faster suppression of effector T cell
responses compared with naive T cell responses. Given their
role in the control of effector T cell activation, it is also attractive
to speculate that not only PTPN22, as reported previously
(Bottini and Peterson, 2014), but also PAG and Dok adaptors
may be implicated in the pathogenesis of disorders involving
repeated or sustained T cell responses in humans, such as
autoimmunity.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J, B10.BR, and RAG-1 KO (Rag1/) mice were obtained from The
Jackson Laboratory. PAG KO (Pag1/) mice, PTPN22 KO (Ptpn22/) mice,
Dok-1 KO (Dok1/) mice, mice carrying a conditional allele of SHIP-1
(Inpp5dfl/fl), and mice lacking c-Cbl and Cbl-b in T cells (Cblfl/fl; Cd4-Cre;
Cblb/) have been described elsewhere (Davidson et al., 2003; Kitaura
et al., 2007; Lindquist et al., 2011; Tarasenko et al., 2007; Yang and Seed,
2003). Mice expressing the Cre recombinase under the control of the CD4 pro-
moter (Cd4-Cre) were from Taconic. Transgenic mice expressing MHC class
II-restricted TCR OT-II or AND were also reported (Barnden et al., 1998;
Kaye et al., 1989). All mice were maintained in the C57BL/6 background.
Littermates were used as controls in all experiments. Animal experimentation
was done in accordance with the Canadian Council of Animal Care and
approved by the Institut de recherches cliniques de Montre´al (IRCM) Animal
Care Committee.
Cells
Freshly isolated CD4+ T cells were obtained from the spleen using a purifica-
tion kit (STEMCELL Technologies) or a Dynabead CD4+ T cell enrichment kit
(Thermo Fisher Scientific). Cell purity was consistently greater than 90%
(data not shown). In some experiments, naive CD4+ T cells were purified by
cell sorting. Purity was greater than 99%. Previously activated CD4+ T cells
were generated by stimulating purified cells with anti-CD3 (3 mg/mL) immobi-
lized on plastic and soluble anti-CD28 (1 mg/mL) for 2 days and then expansion
in IL-2 (50 units/mL) for 3 days.
T Cell Activation Assays
CD4+ T cells were activated with anti-CD3 or anti-TCR with or without
anti-CD28. For stimulation with superantigen, CD4+ T cells were incubated
with the indicated concentrations of SEB (Sigma-Aldrich) in the presence of
irradiated splenocytes from C57BL/6 mice. For stimulation with antigenic
peptides, T cells were activated with the indicated concentrations of OVA
peptide (323–339) or PCC peptide (88–104) in the presence of irradiated
splenocytes from C57BL/6 or B10.BR mice, respectively. As a control,
cells were activated with PMA (100 ng/ml) and ionomycin (1 mM). Pro-
liferation was measured by [3H]-thymidine incorporation, and cytokine
production was assessed by ELISA (R&D Systems). All assays were done
in triplicate.
Immunization with Ovalbumin
Mice were immunized in the foot pad with OVA protein (100 mg, Sigma-
Aldrich) in the presence of complete Freund adjuvant (CFA, Sigma-Aldrich).
After 9 days, CD4+ T cells were isolated from popliteal lymph nodes and
re-stimulated in vitro with the indicated concentrations of OVA and irra-
diated splenocytes or with P+I. Proliferation and cytokine production were
determined.
Biochemical Assays
Cells were stimulated for the indicated times at 37C with biotinylated
anti-CD3 or anti-TCR, with or without anti-CD28, and avidin. After lysis in mal-
toside-containing buffer supplemented with protease and phosphatase inhib-
itors, lysates were processed for immunoprecipitation or immunoblotting
(Davidson et al., 2003, 2007, 2010). Quantification of blots was performed
with ImageJ software.
EAE
Mice were injected sub-cutaneously with MOG peptide 35–55 in CFA plus
Mycobacterium tuberculosis H37Ra (Difco Laboratories), followed 24 and
72 hr later by injection of pertussis toxin as described (Davidson et al.,
2010). In some experiments, a booster was administered on day 35. Mice
were scored regularly for neurological deficits as follows: 0, no clinical signs;
1, loss of tail tonicity; 2, flaccid tail; 3, hindleg paralysis; 4, hindleg paralysis
with hindbody paresis; 5, hind- and foreleg paralysis. After 6 weeks, splenic
CD4+ T cells were re-stimulated in vitro with MOG peptide plus irradiated sple-
nocytes or with P+I. For adoptive transfer, CD4+ T cells fromMOG-immunized
mice were purified 10 days after immunization and re-stimulated in vitro
with MOG peptide plus irradiated splenocytes in the presence of IL-23
(10 ng/mL) and anti-IFN-g (10 mg/mL) to expand MOG-specific TH17 cells.
After 5 days, T cells were injected into RAG-1 KO mice. 24 hr later, pertussis
toxin was injected into the recipient mice. The mice were then monitored
for EAE.
Statistical Analyses
Prism 6 software was used for unpaired or paired Student’s t tests (two-tailed),
non-parametric Wilcoxon matched-pairs t test, or one-way ANOVA followed
by Tukey’s or Dunnett’s multiple comparison test when appropriate.
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